Galactan-binding antibodies. Diversity and structure of idiotypes by unknown
GALACTAN-BINDING  ANTIBODIES 
Diversity and Structure of Idiotypes 
BY  STUART RUDIKOFF,  MICHAEL PAWLITA, JANET PUMPHREY, 
ELIZABETH MUSHINSKI,  AND MICHAEL POTTER 
From the Laboratory of Genetics, National Cancer Institute, National Institutes of Health, 
Bethesda,  Mar~,land  20205 
Two of the intriguing questions in immunology, which in many instances may 
be  related,  are  the  mechanisms by  which  the  vast  array  of immunoglobulin 
diversity is generated and the structure of antigenic determinants associated with 
these molecules. It is now clear that several processes contribute to immunoglob- 
ulin diversity. First, there are an apparently large number of both light (L)  ~ and 
heavy  (H)  chain  germline  genes  (1-4).  Second,  both  L  (5-8)  and  H  (9-18) 
polypeptide chains are encoded in multiple genetic elements, and various com- 
binations  of these  segments  produce  a  large  amount  of structural  diversity. 
Third, the joining of these various gene segments may not be precise (6-8,  11- 
13,  17-21), resulting in diversity at the points of recombination. Fourth, L and 
H chains may randomly pair, although the actual extent of such chain 'shuffling' 
is  undetermined. Fifth,  somatic  point  mutations occur that  impose additional 
diversity on the system (22-29). Sixth, gene interaction (such as gene conversion) 
among related  members of immunoglobulin variable (V) region families may 
alter primary sequences (30-32).  It is thus of interest to analyze the primary 
structure of groups of related antibodies in terms of the genetic mechanisms that 
have  contributed  to  the  generation  of individual  molecules.  Comparison  of 
related antibodies further presents the opportunity to assess  the structural basis 
of antigenic determinants associated with these molecules and analyze the role 
of the various genetic processes in the generation of these markers. 
Since  the  original  discovery in  humans  (33)  and  rabbits  (34)  of individual 
antigenic specificities (subsequently termed idiotypes) associated with homoge- 
neous immunoglobulins, the structure and potential biologic role of these mark- 
ers have been of great interest in the field of immunology. Numerous idiotypic 
systems have been generated and studied in great detail in a variety of species. 
Most of these studies have dealt with serological characterization of the antibodies 
involved and very little is known about the molecular basis of idiotypy. Interest 
in the potential role of idiotypes as biological regulators has been stimulated by 
the proposal of  Jerne (35) suggesting that these determinants constitute a network 
that may serve to regulate the immune response. In view of the potential value 
of idiotypes  as  models  for  protein  antigens,  as  well  as  their  possible  role  in 
immune regulation, it is important to understand the molecular basis of these 
determinants.  One of the  systems being  used  in  this  laboratory to  assess  this 
Abbreviations used in this paper:  L, light chain; H, heavy  chain; V, variable  region. 
Journal of Experimental  Medicine • Volume 158, November 1983  1385-1400  1  385 1386  IMMUNOGLOBULIN  DIVERSITY  AND  IDIOTYPES 
question  consists of myeloma and  hybridoma antibodies directed to  /3(1,6)-D- 
galactan moieties. In the present communication we report idiotypic serological 
analysis and complete H  chain V region sequences from eight of these proteins. 
These results have permitted the subsequent assignment of the molecular basis 
of a number of idiotypes associated with galactan-binding antibodies, as well as 
provided insights into the genetic mechanisms contributing to the structure of 
these proteins. 
Materials  and  Methods 
Antisera and Serological Assays.  Antiidiotypic antisera were prepared in A/He and SJL/ 
J mice and tested in a solid-phase radioimmunoassay as previously described (36). Briefly, 
antisera  were first assayed for direct binding of ~25I-labeled immunogen. The highest 
dilution giving reproducible binding (usually ~ 2,000 cpm) was then used in a competition 
assay using  various  'cold' hybridoma and  myeloma proteins to compete with  labeled 
immunogen. 
Proteins.  The production and characterization of hybridoma proteins with specificity 
for 13(1,6)-D-galactan has previously been reported (37). These hybridomas were derived 
from three separate fusions. Hybridoma proteins included in the present studies were of 
the IgM class and myeloma proteins were of the IgA class. All antibodies were purified 
by affinity chromatography (38). 
Peptides and Sequence Determination.  H  chains were cleaved with cyanogen bromide 
(19) and the resulting fragments separated on a Sephadex G-100 column equilibrated in 
5 M guanidine-0.2 M NH4HCO3. Peptides  linked by disulfide bonds were completely 
reduced, 14C-alkylated, and resolved on a Bio-Gel A, 0.5 M agarose column equilibrated 
in 6 M guanidinium-Tris buffer, pH 8.0. Sequence determinations were performed on a 
modified Beckman 890C sequencer (Beckman Instruments, Inc., Fullerton, CA) (30) and 
the phenylthiohydantoin  derivatives obtained after each degradation cycle were identified 
by high pressure liquid chromatography (39). 
Results 
Sequence  Determination.  H  chain  V  region  peptides  were  isolated  and  se- 
quenced as previously described (30). Complete V region sequences from eight 
H  chains are presented  in  Fig.  1 along  with  sequences of myeloma proteins 
previously reported (10). Four of the hybridoma H chains, HyGal 1, 2, 3, and 4, 
are identical  to  each other and  to  the myeloma proteins  X44  and  T601  for 
amino acids 1-94, the region encoded by the V. gene segment. Proteins HyGal 
6,  11, and  12 share the same Asp-Glu substitution at position 46.  HyGal 6 has 
two additional substitutions at residues 45 and 91.  HyGal  10 differs from the 
prototype sequence at positions 60, 88, and 91. The D regions of all hybridoma 
proteins except HyGal 11 and 12 differ and the D region of HyGal 3 is identical 
to those of T601  and X24. At least three JH regions are expressed among these 
proteins (Fig.  1) and the HyGal 11 and 12 J, regions have the identical Ala-Asp 
substitution at position  101. 
Idiotypic  Analysis.  Individual allogeneic antisera raised to each of the hybri- 
doma and myeloma proteins were tested in competition assays using each of the 
other galactan-binding proteins as inhibitors (Table I). Antisera to hvbridoma 
proteins HyGal  1,  2,  and 4  and myeloma proteins X24,  X44,  and J539  were 
considered to be specific for the immunogen and showed essentially no cross- 
reactivity. In contrast, antisera to hybridoma HyGal 3 cross-reacted with proteins 
HyGal 2, T601, and X24. Antisera to HyGal 6 reacted equally well with HyGal X44 
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FIGURE  1.  Complete H chain V region sequences from BALB/c galactan-binding hybridoma 
proteins. Sequences for the myeloma proteins X44, T601, X24, and J539 are from reference 
10. Numbers at the bottom indicate positions at which substitutions occur compared with the 
X44 sequence, which is exactly encoded by a  BALB/c V. gene (42). Numbering is according 
to Kabat et al. (57). Gin-81 in HG3 and Thr-44 in HG11 are tentative assignments. 
TABLE  I 
Idiotype Expression by Galactan-binding Antibodies* 
Idiotypic systems* 
Inhibitors 
HG1  HG2  HG3  HG4  HG6  HG10  HG12  T601  X44  X24  J539 
Hybridomas 
HG1  []  >  >  >  >  >  >  >  >  >  > 
HG2  >  []  ~  >  >  >  ~  >  >  >  > 
HG3  300  >  ~  >  >  >  [-~  ~  >  >  > 
HG4  >  >  700  []  >  >  ~  >  >  >  > 
HG6  >  >  >  >,'  []  []  ~  >  >  >  > 
HGIO  >  >  >  >  []  []  V-fOl  >  >  >  > 
HG12  >  >  250  >  >  500  ~  >  >  >  > 
Myelomas 
T601  >  >  ~  >  >  >  >  ~  >  >  > 
X44  >  >  >  >  >  >  >  ~  []  >  > 
X24  >  >  [~  >  >  >  >  ~  >  [~  > 
J539  >  >  >  >  >  >  >  >  >  >  [] 
* Antisera to specified hybridoma or myeloma proteins were tested for competition of binding of 
radiolabeled  imnmnogen.  Values  given  represent  nanograms  required  for  50%  inhibition. 
>  indicates 50% inhibition was not achieved at concentrations of 1,000 ng or greater,  Enclosed 
values represent significant inhibition arbitrarily defined as requiring <20  times the amount of 
homologous protein. 
* Idiotypic antisera were prepared to the hybridoma and myeloma proteins indicated and tested with 
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10 and the reciprocal activity was found with antisera to HyGal  10. Antisera to 
HyGal 12 showed broader specificity than observed in other systems and reacted 
with all  IgM  hybridoma proteins except  HyGal  1,  but with  none of the  IgA 
myeloma proteins.  Antisera to T601  cross-reacted significantly with HyGal  3, 
T601, X24, and X44. 
Discussion 
The study of groups of myeloma and hybridoma proteins with specificity for 
chemically defined haptenic determinants has provided a number of systems that 
have proven to be of great value in the analysis of antibody diversity and the 
structure of idiotypes. One such system being developed in our laboratory consists 
of antibodies with specificity for/3(1,6)-a-galactan  moieties. A  number of mye- 
loma proteins demonstrating this specificity were initially characterized in terms 
of specificity (38,  40),  idiotypy (41),  and  primary  sequence analysis  (10,  19). 
More recently we have generated a series of hybridoma proteins exhibiting the 
same specificity and have reported complete r  chain V region sequences for  10 
of these (37).  In  the present  study we have  determined complete H  chain  V 
region  sequences  for  eight  of the  hybridoma proteins.  In  addition,  idiotypic 
antisera have been raised to each of the hybridoma and myeloma proteins and a 
detailed serological analysis has been performed. The evaluation of this data has 
provided information pertinent to both the generation of antibody diversity and 
the structure of immunoglobulin idiotypes. 
V, Segment Sequence Diversity.  The  H  chain  V  region  is  encoded  in  three 
distinct genetic elements (12, 13) designated VH, D, and JH. The V, gene segment 
encodes  amino  acids  1"~95,  the  D  segment  encodes  a  portion  of the  third 
complementarity determining region, and the JH segment encodes amino acids 
101-113  (Fig.  1).  A  comparison  of the  VH  sequences  in  Fig.  1  reveals  that 
hybridoma proteins HyGal  1, 2, 3, and 4 and myeloma proteins X44 and T601 
are identical for their first 94 amino acids. The VN segment in these proteins is 
likely to be  94  amino acids  in  length,  since  OIlo et  al.  (42)  have  cloned and 
sequenced  a  VH  germline  gene  that  encodes  exactly  this  sequence.  HyGal  6 
differs from this sequence at  three  positions (45,  46,  91),  HyGai  10  at  three 
positions (60,  88,  91),  HyGal  11  at  one  position (46),  and  HyGal  12  at  one 
position (46). The Asp-Glu substitution at position 46 is shared by proteins HyGal 
6,  11,  and  12.  All of these substitutions can  be  accounted for  by single-base 
nucleic acid changes. 
It is of interest to now ask, what is the origin of the V. sequences found in the 
antigalactan hybridomas? The HyGal  1,  2,  3, 4,  X44 and T601  sequences can 
be directly encoded by the VH germline gene sequenced by O11o et al. (42). Our 
laboratory  has prepared  a  cDNA probe to the X24  V, region with which, in 
Southern blot analysis of genomic DNA (A. Hartman and S. Rudikoff, unpub- 
lished results),  we  detected  two hybridizing bands.  Thus,  the  V,  regions  ex- 
pressed in these proteins are likely to be encoded by one or at most two genes. 
If, for example, a second gene encoded the V. segments with Asp at position 46 
(HyGal  6,  11,  12), there would still exist a  number of substitutions apparently 
not encoded in germline genes, i.e., Pro-45 in HyGal 6, Lys-60 in HyGai 10, Gly 
88  in  HyGal  10, and possibly Phe-91  in HyGal  6  and  10.  These substitutions RUDIKOFF  ET  AL.  1389 
would, presumably, have arisen by somatic mutation. Proteins HyGal 11 andl2 
are identical in sequence in both their L and H  chains and originated from the 
same fusion. These hybridomas are therefore probably derivatives of the same 
original clone so that Asp-46  has occurred independently only twice (once in 
HyGal  6  and once in  the  HyGal  11,  12  pair).  HyGal  6  and  10  are  similarly 
notable in that they arose from the same fusion, have identicalJ~ andJH segments, 
and share the Phe-91 substitution. It is thus possible that these hybridomas derive 
from a single precursor that expressed the Phe-91  substitution and have subse- 
quently diversified by additional somatic mutations as observed in Fig. 1. 
The  role  and  time  of occurrence of somatic  mutation  in  immunoglobulin 
diversity has  long been a  subject of controversy. The  occurrence of somatic 
mutation in immunoglobulin genes has been well documented (22-29) and more 
recently it has been suggested (25-27) that the somatic mutation process is linked 
to Ig class  switching. The fact that the galactan-binding IgA myeloma proteins 
have a number of substitutions likely resulting from somatic mutation is consistent 
with this interpretation.  However, the putative somatic mutations observed in 
the IgM hybridoma proteins are not associated with class switching. We interpret 
the present data to indicate that somatic mutation does occur in IgM antibodies. 
It has been suggested (37, 43) that the failure to previously detect this type of 
event in IgM-producing cells is related to the observation that IgM-producing 
cells are not derived from a  memory population.  Thus,  IgM-producing cells, 
including those expressing somatic mutations, would be rapidly turned over and 
lost from the population. Lymphocytes expressing other H chain classes do arise 
from a  memory pool  and might thus have a  higher probability of exhibiting 
somatic mutations if this process is correlated with time. At present, there is no 
direct evidence linking the occurrence of somatic mutation to class  switching 
although this possibility certainly exists. 
Complementarity-determining Region 3 and D Segments.  An exam,  ination of Fig. 
1 reveals that all of the hybridoma proteins are identical in CDR-1  and -2 (H1, 
H2) with the exception of a single substitution in CDR-2 of HyGal 10. However, 
CDR-3  (H3)  shows a  high  degree of sequence variation.  This  region  of the 
molecule is of particular interest in that a portion of CDR-3 is encoded by the D 
gene and this region is also the site of two recombination events, VH-D and D-JH. 
We have analyzed the CDR-3 sequences in terms of their origin and this data 
is presented in Fig. 2.  Numbering in the figure differs from that in Fig.  1 and 
has been adapted to best present the derivation of amino acids found in CDR-3. 
The consensus protein sequence found in Fig.  1 is presented at the top of the 
figure. The end of the V. segment has been assigned to position 94 based on 
the VH gene sequence determined by Ollo et ai. (42) and the J. sequences at the 
right-hand side are those of the three JH segments used in the galactan-binding 
antibodies. It can be seen that the 'core' sequence of CDR-3, designated D, can 
be encoded by at least six different germline D  genes (18) listed in the lower 
portion of the figure. However, it is readily apparent that a  number of amino 
acids are present on both the NH2- and carboxy-terminal sides of the D segment 
(designated x and y, respectively) which are not encoded in these or any other 
known germline D  segments, and are presumably generated during the VH-D 
and D-J. recombination events (see below). 1390  IMMUNOGLOBULIN  DIVERSITY  AND  IDIOTYPES 
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FIGURE 2.  H chain CDR-3 sequences found in galactan-binding  hybridoma and myeloma 
proteins. The x and y regions designate  amino acids on the NH~ and COOH sides of the D 
segment that are not encoded by germline D genes. The prototype  sequence R-L-G-Y-Y-G-Y- 
Y-F-A-Y represents the most frequent amino  acid found at the designated  position although 
this exact sequence is not expressed in any of the hybridoma  or myeloma  proteins. The germ- 
line D sequences are translates  of the corresponding  germline genes. 
The derivation of several of the D region sequences appears relatively unam- 
biguous. The HyGal 4 D region is directly encoded by the DFL 16.1  gene. This 
D gene probably also encodes the HyGal  11  and  12  D regions. Three of the 
amino acids in the HyGal 11  D region are directly encoded by DFL 16.1.  The 
germline codon for Tyr-96C is TAT and an alteration of this codon to GAT 
during VH-D recombination would produce the Asp-96  observed in HyGal  11 
and 12. The D regions of HyGal 1, 2, 3, 6, 10, T601, and X24 could be encoded 
by several of the listed D region genes. The X44 and J539 D segments may be 
encoded by the DFL 16.2 gene since translation of the trinucleotide 5' to that 
encoding Tyr-97 would produce the His observed at position 96.  The portion 
of CDR-3 encoded by the D gene appears to vary from 2 (HyGal 1) to 6 amino 
acids although, as will be seen below, the recombination events compensate to 
maintain a uniform length in CDR-3. 
Probably the most striking feature of Fig. 2 is the number of amino acids NH2- 
and carboxy-terminal (x and y) to those encoded by germline D segments. None 
of these sequences appear to be encoded in D genes and are unlikely to have 
been generated by D-D  fusion. It has previously been suggested (44,  45)  that 
nucleotides encoding amino acids on  the  5'  and  3'  sides  of D  segments are 
generated by repair enzymes such as terminal transferase. Most of the amino 
acids in the x and y regions of the galactan-binding H  chains are high in G-C 
content, which is consistent with the proposed use of terminal transferase as a 
means for introducing amino acids in these areas. An example of the potential 
role of repair enzymes in the generation of sequences in the x and y regions is 
presented for the HyGal 12 sequence. In HyGal 12. which we assume uses DFL RUDIKOFF ET  AL.  1391 
16.1, it is necessary to generate Leu-95, Asp-96 during VH-D recombination and 
Arg-100b during D-J~ recombination. A  possible scheme for these events is as 
follows: 
DFL 16.1 
Arg  L  Phe 
V,- AGA-C CC  TAC  TTT-J2 
l  g  I  TC- G  G 
[sP  Tyr  Tyr  GIy  Ar  I 
TAT-TAC-  TAC-  GGT-A-GT 
The first nucleotide of Leu-95 would be contributed by the codon 3' to the V. 
gene (CCC). The remaining two nucleotides (TC) and the first nucleotide (G) of 
Asp-96 would be added by terminal transferase (TT), followed by recombination 
with DFL 16.1 as indicated. On the 3' side the first two nucleotides of the AGT 
(Ser) codon would be used, followed by an addition of G by terminal transferase 
to generate Arg  100b (AGG) and recombination with J2.  Similar schemes can 
be devised to account for most of the sequences in the x and y regions. 
D Region  Function.  Examination of the CDR-3 and D sequences (Figs.  1 and 
2) reveals that only Gly-99 is invariant and that a  large amount of amino acid 
sequence variation is present in this region of the molecule. It should be noted 
that all hybridomas were induced by immunization with /3(1,6)-D-galactan  con- 
taining antigens and were hapten eluted from affinity columns. Therefore, the 
variation in CDR-3 contributed by D region sequence and the two joining events 
produces no significant alteration in specificity. Furthermore, the L chains used 
in these antibodies are essentially identical (37), indicating that these CDR-3 and 
D region sequences do not effect H  and L pairing. The only constant feature of 
this region of the molecule is the invariant length of CDR-3. The length of CDR- 
3 may thus be important in either the general architecture of the binding site or 
the ability of these H chains to pair with a proper L chain, but the primary amino 
acid sequence seems relatively unimportant. We have made similar observations 
for  phosphocholine and  dextran-binding  antibodies  (45,  46).  It  is  somewhat 
surprising to find that  in  the first three  systems studied in appropriate  detail 
(phosphocholine, dextran, and galactan),  D region sequence appears to play no 
important role in either the determination of antigen-binding specificity or in 
H-L pairing. 
Alternate Frames of Recombination.  In spite of the variation in length of the D 
segment (two to six amino acids) the length of CDR-3 invariably consists of nine 
amino acids between positions 95 and 101 (Figs. 1 and 2). The variation in length 
of the D  segment is compensated by alterations in the frame of VH-D recombi- 
nation on the 5' side of D and D-JH recombination on the 3' side to maintain the 
length of CDR-3.  Examples of this alteration in recombination sites between D 
and J  are presented in Fig. 3.  By similar alterations in the V,-D recombination 1392  IMMUNOGLOBULIN DIVERSITY AND  IDIOTYPES 
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Alternate sites of D-JH recombination  in galactan-binding  antibodies. 
sites, the length of CDR-3 is maintained, implying that this conserved length is 
probably critical to some functional aspect of these H chains. 
Idiotypes.  Idiotypic markers,  which  may be  defined generally as  antigenic 
determinants within the immunoglobulin V region, have proven to be extremely 
valuable tools in the areas of immunogenetics and structure-function relation- 
ships.  More recently, interest in idiotypes has expanded with the hypothesis of 
Jerne (35) suggesting these markers may be recognition sites for the regulation 
of immune  responses.  Unlike  the  constant  region  allotypes,  which  in  many 
instances are simple in nature and determined by one or a few amino acids (47), 
idiotypes appear  to  be  quite  complex and have been difficult to  characterize 
structurally (reviewed in 46). 
Idiotypes  of Galactan-binding  Hybridomas  Are  Located in  the  H  Chain  CDR-3 
Region.  We have approached the problem of the structural basis of idiotypes by 
isolating a group of antibodies reacting with the same haptenic determinant and 
performing complete L and H  chain V region sequence analysis in conjunction 
with serologic antiidiotypic studies. The combined results of these studies now 
permit an  assessment  of the  structural  basis  of idiotypes expressed  on  these 
molecules. 
We have previously reported (37) complete L chain V region sequences for all 
proteins  included  in  the  present  study.  The  L  chains  from  seven  of eight 
hybridomas and two rnyelomas, X24 and T601, are identical throughout their 
V~ regions but use different J~ segments. The HyGal 6 L chain has a single Ala- 
Val substitution at position  12.  However, this substitution is not involved in an 
idiotypic determinant, as antisera to HyGal 6 react equally well with HyGal  10 
(Table  I),  which  expresses  the  'germline'  Ala  at  this  residue.  Similarly,  no 
common reaction pattern  is  observed among proteins sharing the same J~ se- 
quence, indicating J~ is not a primary source of idiotypic determinants. Two of 
the myeloma L chains, J539 and X44, have V~ substitutions that may contribute 
to idiotypic markers. The structural basis of idiotypes associated with all hybri- 
doma as well as myeloma proteins X24 and T601  must therefore reside in the 
H  chains. Previous experiments using recombinant molecules made among the RUDIKOFF  ET  AL.  1393 
myeloma proteins have likewise shown that idiotypes expressed on these mole- 
cules are determined by the H chain sequence (48). 
Examination of the H  chain sequences (Fig.  1) reveals very few substitutions 
in the V. segments (amino acids  1-94).  Three proteins,  HyGal 6,  11,  and  12 
share the same Asp-46 substitution. However, antisera to HyGal 6 do not cross- 
react with HyGal 12 and antisera to HyGal 12 cross-react with HyGal 6 as well 
as proteins with glutamic acid at residue 46, indicating Asp-46 is not an idiotype- 
determining residue. Similarly, no common reaction pattern is observed among 
proteins  with  Glu  at  position  46.  Since  HyGal  6  and  10  show  strong  cross- 
reactivity,  the  Pro-45  substitution  in  HyGal  6  and  the  Lys-60  and  Gly-88 
substitutions in HyGal  10, by the same argument, are not the basis of idiotypic 
determinants.  The  shared  Tyr-Phe  substitution  at  residue  91  in  these  two 
proteins is also not a likely source of idiotypic determinants (see below). The lack 
of cross-reactions among proteins sharing the same J. segment also eliminates 
this region as a  primary idiotypic determinant. Two of the myeloma proteins, 
X24 and J539,  have multiple V. substitutions that are all potentially available 
for involvement in antigenic markers. Thus, idiotype-determining residues in all 
hybridoma proteins, as well as myeloma proteins X44 and T601, reside in the 
CDR-3 region and result either from (a) the D segment, (b) the two recombina- 
tion  events occurring in  this  region,  or  (c)  combinations of the above  three 
elements. 
Structural Basis ofAntigalactan Idiotypes.  Since most idiotypes expressed on the 
galactan-binding  antibodies  are  localized  in  CDR-3,  an  examination  of the 
sequences in this area (Fig. 4) along with the serologic analysis (Table I) permits 
a definition of the structural basis of many of these markers. It should be kept 
in  mind  that  these  markers  may  be  complex  in  nature  and  involve  three- 
dimensional interactions presently unknown, including invariant portions of the 
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FIGURE  4.  Correlation  of  idiotype  expression  and  H  chain  CDR-3  sequences.  Circled  or 
boxed amino acids represent residues most likely involved in the determination of idiotypes as 
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molecule. In this regard, a  hypothetical three-dimensional model of a  galactan- 
binding antibody  has  been  constructed  along  lines  previously  described  (49), 
which,  within  the  limits of model building,  suggests that  the CDR-3  region  is 
exposed to solvent and positioned such that it might be expected to be accessible 
to antiidiotypic antibodies (Fig. 5). 
HyGal 1.  Idiotypic antisera to HyGal  1 (Table I) were essentially specific for 
the immunogen although weak cross-reactivity with HyGal 3 was observed. The 
CDR-3  sequence of HyGal  1 (Fig.  4) is unique, as might be expected from the 
serological analysis, and displays little homology with the other proteins. 
HyGal 2.  Antisera to HyGal 2 show no cross-reactivity with other proteins in 
the group. However, HyGal 2 is highly homologous to HyGal 3, T601, and X24 
with  differences  occurring  only  at  positions  95,  100a,  and  101.  This  result 
indicates that Aia-95 or Set-100a are dominant determinants which alter or mask 
the central  sequence (amino acids  96-100)  such  that antisera  to the  HyGal  2 
immunogen are  non-cross-reactive.  It  is  more  likely  that  these  residues  are 
dominant determinants in that antisera to HyGal  3 also cross-react with HyGal 
2. 
HyGal 3.  Antisera  to  HyGal  3  cross-react  with  HyGal  2,  T601,  and  X24. 
Proteins HyGai 3, T601, and X24 have identical sequences from positions 95 to 
101 and HyGal 2 differs only at positions 95,  100a, and  101. The strong cross- 
reactivity between  HyGal  2 and 3  suggests that a  significant portion of antiidi- 
otypic antibody in this sera is directed to the sequence including positions 96- 
FIGURE 5.  Hypothetical three-dimensional model of the galactan-binding myeloma protein 
J539. Colors are as follows:  L chain, black; H chain, grey; H chain CDR-3 region, white. RUDIKOFF  ET  AL.  1395 
100, which makes this group unique when compared with the other members. 
Proteins HyGai 4 and 12, which share a portion of this sequence, were found to 
weakly inhibit. The complexity, as well as the precise requirements of determi- 
nants such as these,  is pointed out by the failure of X44 and J539  to inhibit. 
Based on sequence comparisons, these proteins might well be expected to inhibit 
this antisera as well as HyGal 4 and 12. 
Antisera to  T601  react with  HyGal  3  and X24  to approximately the same 
extent, but do not react with HyGal 2, suggesting that either or both positions 
95 and 100a are important in the generation of this determinant. Neither Leu- 
95 nor Phe-100a alone can be dominant residues since other proteins expressing 
these amino acids  do  not  inhibit.  These  residues  must  therefore function in 
association with adjacent amino acids to produce the cross-reactive determinant 
recognized in this system. It seems possible that Phe-100a and Asp-101  are the 
more important idiotype-determining amino acids since this sequence is unique 
to proteins HyGal 3, X24, and T601. X44 also inhibits this system although the 
basis  for this  reactivity is  not obvious and  X44  lacks Phe-100a  and Asp-101, 
which correlate with idiotype expression in the other molecules. The variation 
in reactivity patterns between antisera to HyGal 3 and T601  points out the fact 
that individual antisera may recognize the same protein sequence differently. 
HyGal 4.  Antisera to HyGal 4 were specific for the immunogen. The HyGal 
4 CDR-3 sequence has unique substitutions at positions 96 (Tyr) and 100 (Ser). 
Either or both of these residues are therefore idiotype determining. 
HyGal 6 and 10.  Antisera to HyGal 6 react equally well with HyGal  10 and 
the reciprocal reactivity is seen with antisera to HyGal 10.  These antisera show 
no significant additional cross-reactions with other members of the group. The 
CDR-3 protein sequences from HyGal 6 and 10 are identical from positions 95 
to 99 and both express the unique His-97 substitution, which distinguishes these 
two proteins in this region. Additionally these proteins share the Phe-91 substi- 
tution (Fig.  1) in the framework region adjacent to CDR-3. However, the three- 
dimensional structure of the galactan-binding myeloma protein J539 (50; D. R. 
Davies, personal communication), indicates that position 91  is buried in the L-H 
interface and would not be accessible as an idiotype-determining residue. Thus, 
His-97 is likely to be the dominant amino acid in the determination of this shared 
idiotype. 
HyGal 12.  Antisera to HyGal  12 cross-react broadly with most of the hybri- 
doma proteins, yet do not react with other IgM molecules, indicating that this 
reactivity is not aliotypic. The hybridoma proteins inhibiting this system share 
the common sequence Tyr-98, Gly-99, yet myeloma proteins of the IgA class 
with an identical sequence fail to inhibit. This result suggests that the CHI domain 
may effect the expression of idiotypes recognized by this antisera. Similar results 
have been reported for a monoclonal antibody to phosphocholine (51). 
X44.  Antisera to X44 are inhibited only by the immunogen, and this CDR-3 
sequence is distinguished by the amino acids His-96 and Ala-100a. J539  shares 
the same His-96 substitution (but differs at 100a) and does not inhibit this system. 
Additionally, the X44 L chain differs from the other L chains in this group by a 
Trp-Ile interchange at position 96, the point of V,-J, recombination. However, 
position L-96 is buried in the interior of the molecule and would not contribute 1396  IMMUNOGLOBULIN  DIVERSITY  AND  1DIOTYPES 
to surface determinants. The predominant idiotype-determining residue is there- 
fore Ala-100a in the H chain. 
X24.  A/J antisera to X24 are specific to the immunogen, although this protein 
is  inhibitory in  both  the  HyGal  3  and T601  systems described above.  Thus, 
antisera to X24 do not appear to be directed to the CDR-3 sequence shared with 
proteins T601  and HyGal 3.  Although X24 has a  number of V, substitutions 
(Fig.  1),  we  have  previously concluded that  the  idiotype  recognized by  this 
antisera is  likely to  be determined by Gly-53  (52).  In contrast,  a  monoclonal 
antibody to X24 was found to cross-react moderately with X44 and weakly with 
several other of the galactan-binding myeloma proteins (36). 
J539.  Antisera to J539  were unique for the immunogen. J539  expresses a 
number of substitutions  throughout the  H  chain  V  region as  well as  the  VK 
segment, making it impossible to assign idiotypic correlates. 
The above analysis has provided the opportunity to describe at the molecular 
level the likely basis for a  number of idiotypes expressed by a  group of closely 
related proteins. Some of these idiotypes, such as those identified by the HyGal 
3 and HyGal 6 systems, are shared while others are unique. The CDR-3 sequences 
of these proteins (Fig.  4) point out the dramatic effect of relatively few amino 
acid changes on the expression of idiotypes. For example, the idiotype-determin- 
ing residues  in  the cross-reactive HyGal  3  system largely include the central 
sequence of CDR-3. Yet proteins HyGal 12, X44, and  J539, which differ by only 
two amino acids each in this region, either fail to inhibit or at best inhibit weakly. 
Thus,  this  small  number of substitutions  has  resulted  in  a  loss  or  significant 
alteration of idiotype expression accompanied by the generation of new deter- 
minants.  This  is  further  illustrated  by  proteins  HyGai  6  and  10,  which  are 
distinguished primarily by a single substitution at residue 97. Antisera to either 
of these proteins are inhibited to the same extent by both, yet no other proteins 
react in these systems. Thus, proteins that are nearly 99% homologous in their 
sequences may be completely different idiotypically depending on the particular 
reagent used. Taken together, these results point out the complex interactions 
of amino acids in CDR-3 that generate the observed idiotypic determinants and 
the very pronounced effect resulting from perturbation of these structures. 
The study of the structural basis of idiotypy is still in its early stages (reviewed 
in  46) and very few systems to date have been amenable to rigorous analysis. 
Two L chain idiotypes have been defined on inulin-binding myeloma proteins 
(53,  54).  The most comprehensive data to date on idiotype structure has been 
derived from the study of antibodies that bind  a(1,3) dextran (55,  56).  Two 
classes of idiotypes have been described in this system. The first, a cross-reacting 
idiotype located in CDR-2, and the second, a series of individual idiotypes located 
in the CDR-3 region, as is the case for the galactan-binding antibodies described 
above. It should be noted that the assignment of the dextran markers assumes 
that all of the L chains (which are ~, type) are likely to be identical although this 
has not been proven experimentally. Thus,  in  both  the galactan and dextran 
systems it is possible to define at the molecular level the structural basis for a 
number of both cross-reacting and individual idiotypes. 
Possible Functional Role ofldiotypes.  It is interesting that in the galactan system 
apparently all of the idiotypic determinants recognized by homologous antisera RUDIKOFF ET  AL.  1397 
reside in the most variable part of the immunoglobulin  molecule, CDR-3. This 
observation  raises  provocative  questions  concerning  the  nature  and  role  of 
idiotypes in immune regulation.  For example, if autologous antiidiotype recog- 
nized similar determinants,  an apparently large number of antiidiotypes would 
be required to regulate this response, or auto-antiidiotype must recognize differ- 
ent  determinants.  Furthermore,  it  is  unclear  whether  autologous antiidiotype 
can be made in vivo to determinants  such as these which presumably occur on 
'natural'  antibody. Thus,  while we have now begun to approach the molecular 
basis of idiotypy, additional  questions have been raised as to the role of these 
markers in immune regulation. 
Summary 
A  group  of eight  IgM  hybridoma  proteins  induced  with  3(1,6)-D-galactan- 
containing  antigens  has  been  characterized•  in  terms  of primary  amino  acid 
sequence and idiotype expression. The H chain amino acid sequences reveal very 
strong homology in the V, segment although several substitutions are seen that 
suggest the occurrence of somatic mutation in these IgM molecules. Significant 
sequence  variation  was  observed  in  CDR-3,  the  region  generated  by  the  D 
segment,  and  the  two recombination  events,  V.-D and  D-J,.  The  number  of 
amino acids in this region contributed by the D segment was found to vary from 
two to  six,  yet the  overall  length  of CDR-3  was precisely  maintained  by the 
addition of amino acids on either side of D during the recombination processes. 
These additional  amino acids are suggested to result from nucleotide addition 
by repair  enzymes.  Idiotypic analysis of these proteins,  in conjunction  with an 
assessment  of the  H  chain  sequences,  has  permitted  an  identification  of the 
molecular  basis  of both  cross-reacting  and  unique  idiotypic  determinants  ex- 
pressed by these molecules. 
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